Human embryonic stem cells: Current technologies and emerging industrial applications

Critical Reviews in Oncology/Hematology

Volumn 65, Issue 1, 2008, Pages 54-80

  Améen, Caroline ^a   Strehl, Raimund ^a   Björquist, Petter ^a   Lindahl, Anders ^b   Hyllner, Johan ^a   Sartipy, Peter ^a  

^a Cellartis AB   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiomyocytes; Differentiation; Drug discovery; Hepatocytes; Human embryonic stem cells; Regenerative medicine; Toxicology

Indexed keywords

CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CELL SELECTION; CELL THERAPY; CELL TYPE; DRUG SCREENING; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; HEART; HEART MUSCLE CELL; HUMAN; LIVER CELL; MEDICAL TECHNOLOGY; PLURIPOTENT STEM CELL; QUALITY CONTROL; REGENERATIVE MEDICINE; REVIEW; TOXICITY TESTING;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; DRUG DESIGN; EMBRYONIC STEM CELLS; HEPATOCYTES; HUMANS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; QUALITY CONTROL; REGENERATION;

EID: 36849049789     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2007.06.012     Document Type: Review

References (259)

1. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
2. Vats A., Bielby R.C., Tolley N.S., Nerem R., and Polak J.M. Stem cells. Lancet 366 (2005) 592-602
3. Heins N., Englund M.C., Sjoblom C., et al. Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 22 (2004) 367-376
4. Amit M., and Itskovitz-Eldor J. Derivation and spontaneous differentiation of human embryonic stem cells. J Anat 200 (2002) 225-232
5. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., and Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18 (2000) 399-404
6. Stojkovic M., Lako M., Stojkovic P., et al. Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture. Stem Cells 22 (2004) 790-797
7. Baharvand H., Ashtiani S.K., Valojerdi M.R., Shahverdi A., Taee A., and Sabour D. Establishment and in vitro differentiation of a new embryonic stem cell line from human blastocyst. Differentiation 72 (2004) 224-229
8. Kim H.S., Oh S.K., Park Y.B., et al. Methods for derivation of human embryonic stem cells. Stem Cells 23 (2005) 1228-1233
9. Xu R.H., Chen X., Li D.S., et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 20 (2002) 1261-1264
10. Lim J.W., and Bodnar A. Proteome analysis of conditioned medium from mouse embryonic fibroblast feeder layers which support the growth of human embryonic stem cells. Proteomics 2 (2002) 1187-1203
11. Carpenter M.K., Rosler E.S., Fisk G.J., et al. Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev Dyn 229 (2004) 243-258
12. Rosler E.S., Fisk G.J., Ares X., et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn 229 (2004) 259-274
13. Sjogren-Jansson E., Zetterstrom M., Moya K., Lindqvist J., Strehl R., and Eriksson P.S. Large-scale propagation of four undifferentiated human embryonic stem cell lines in a feeder-free culture system. Dev Dyn 233 (2005) 1304-1314
14. Xu C., Inokuma M.S., Denham J., et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19 (2001) 971-974
15. Sato N., Meijer L., Skaltsounis L., Greengard P., and Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10 (2004) 55-63
16. Amit M., Margulets V., Segev H., et al. Human feeder layers for human embryonic stem cells. Biol Reprod 68 (2003) 2150-2156
17. Wang G., Zhang H., Zhao Y., et al. Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem Biophys Res Commun 330 (2005) 934-942
18. Levenstein M.E., Ludwig T.E., Xu R.H., et al. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells 24 (2006) 568-574
19. Amit M., Shariki C., Margulets V., and Itskovitz-Eldor J. Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 70 (2004) 837-845
20. Cowan C.A., Klimanskaya I., McMahon J., et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350 (2004) 1353-1356
21. Richards M., Fong C.Y., Chan W.K., Wong P.C., and Bongso A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 20 (2002) 933-936
22. Xu R.H., Peck R.M., Li D.S., Feng X., Ludwig T., and Thomson J.A. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Meth 2 (2005) 185-190
23. Brimble S.N., Zeng X., Weiler D.A., et al. Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 13 (2004) 585-597
24. Buzzard J.J., Gough N.M., Crook J.M., and Colman A. Karyotype of human ES cells during extended culture. Nat Biotechnol 22 (2004) 381-382 author reply 2
25. Draper J.S., Smith K., Gokhale P., et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22 (2004) 53-54
26. Mitalipova M.M., Rao R.R., Hoyer D.M., et al. Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 23 (2005) 19-20
27. Reubinoff B.E., Pera M.F., Vajta G., and Trounson A.O. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod 16 (2001) 2187-2194
28. Richards M., Fong C.Y., Tan S., Chan W.K., and Bongso A. An efficient and safe xeno-free cryopreservation method for the storage of human embryonic stem cells. Stem Cells 22 (2004) 779-789
29. Katkov I.I., Kim M.S., Bajpai R., et al. Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells. Cryobiology 53 (2006) 194-205
30. Heng B.C., Bested S.M., Chan S.H., and Cao T. A proposed design for the cryopreservation of intact and adherent human embryonic stem cell colonies. In Vitro Cell Dev Biol Anim 41 (2005) 77-79
31. Joannides A., Fiore-Heriche C., Westmore K., et al. Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells 24 (2006) 230-235
32. Choo A., Padmanabhan J., Chin A., Fong W.J., and Oh S.K. Immortalized feeders for the scale-up of human embryonic stem cells in feeder and feeder-free conditions. J Biotechnol 122 (2006) 130-141
33. Suemori H., Yasuchika K., Hasegawa K., Fujioka T., Tsuneyoshi N., and Nakatsuji N. Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem Biophys Res Commun 345 (2006) 926-932
34. Ellerstrom C., Strehl R., Noaksson K., Hyllner J., and Semb H. Facilitated expansion of human embryonic stem cells by single cell enzymatic dissociation. Stem Cells (2007)
35. Abranches E., Bekman E., Henrique D., and Cabral J.M. Expansion of mouse embryonic stem cells on microcarriers. Biotechnol Bioeng (2006)
36. Oh S.K., Fong W.J., Teo Y., et al. High density cultures of embryonic stem cells. Biotechnol Bioeng 91 (2005) 523-533
37. Fong W.J., Tan H.L., Choo A., and Oh S.K. Perfusion cultures of human embryonic stem cells. Bioprocess Biosyst Eng 27 (2005) 381-387
38. Gerecht-Nir S., Cohen S., and Itskovitz-Eldor J. Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng 86 (2004) 493-502
39. Cameron C.M., Hu W.S., and Kaufman D.S. Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnol Bioeng 94 (2006) 938-948
40. Gonczol E., Andrews P.W., and Plotkin S.A. Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science 224 (1984) 159-161
41. Itskovitz-Eldor J., Schuldiner M., Karsenti D., et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6 (2000) 88-95
42. Shevinsky L.H., Knowles B.B., Damjanov I., and Solter D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 30 (1982) 697-705
43. Kannagi R., Cochran N.A., Ishigami F., et al. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. Embo J 2 (1983) 2355-2361
44. Andrews P.W., Banting G., Damjanov I., Arnaud D., and Avner P. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 3 (1984) 347-361
45. Pera M.F., Blasco-Lafita M.J., Cooper S., Mason M., Mills J., and Monaghan P. Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells. Differentiation 39 (1988) 139-149
46. Solter D., and Knowles B.B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 75 (1978) 5565-5569
47. Scholer H.R., Ruppert S., Suzuki N., Chowdhury K., and Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature 344 (1990) 435-439
48. Cavaleri F., and Scholer H.R. Nanog: a new recruit to the embryonic stem cell orchestra. Cell 113 (2003) 551-552
49. Avilion A.A., Nicolis S.K., Pevny L.H., Perez L., Vivian N., and Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17 (2003) 126-140
50. Pera M.F., Filipczyk A.A., Hawes S.M., and Laslett A.L. Isolation, characterization, and differentiation of human embryonic stem cells. Meth Enzymol 365 (2003) 429-446
51. Carpenter M.K., Rosler E., and Rao M.S. Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 5 (2003) 79-88
52. Cai J., Chen J., Liu Y., et al. Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells 24 (2006) 516-530
53. Noaksson K., Zoric N., Zeng X., et al. Monitoring differentiation of human embryonic stem cells using real-time PCR. Stem Cells 23 (2005) 1460-1467
54. Hanson C., and Caisander G. Human embryonic stem cells and chromosome stability. Apmis 113 (2005) 751-755
55. Maitra A., Arking D.E., Shivapurkar N., et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet 37 (2005) 1099-1103
56. Caisander G., Park H., Frej K., et al. Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture. Chromosome Res 14 (2006) 131-137
57. Inzunza J., Sahlen S., Holmberg K., et al. Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. Mol Hum Reprod 10 (2004) 461-466
58. Loring J.F., and Rao M.S. Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells 24 (2006) 145-150
59. Griffin C., Waard H., Deans B., and Thacker J. The involvement of key DNA repair pathways in the formation of chromosome rearrangements in embryonic stem cells. DNA Repair (Amst) 4 (2005) 1019-1027
60. Wu H., and Sun Y.E. Epigenetic regulation of stem cell differentiation. Pediatr Res 59 (2006) 21R-25R
61. Allegrucci C., Denning C., Priddle H., and Young L. Stem-cell consequences of embryo epigenetic defects. Lancet 364 (2004) 206-208
62. Chang S.C., Tucker T., Thorogood N.P., and Brown C.J. Mechanisms of X-chromosome inactivation. Front Biosci 11 (2006) 852-866
63. Martin M.J., Muotri A., Gage F., and Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11 (2005) 228-232
64. Hovatta O., Mikkola M., Gertow K., et al. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod 18 (2003) 1404-1409
65. Inzunza J., Gertow K., Stromberg M.A., et al. Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23 (2005) 544-549
66. Richards M., Tan S., Fong C.Y., Biswas A., Chan W.K., and Bongso A. Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cells. Stem Cells 21 (2003) 546-556
67. Stojkovic P., Lako M., Stewart R., et al. An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells 23 (2005) 306-314
68. Ellerstrom C., Strehl R., Moya K., et al. Derivation of a xeno-free human embryonic stem cell line. Stem Cells 24 (2006) 2170-2176
69. Li Y., Powell S., Brunette E., Lebkowski J., and Mandalam R. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng 91 (2005) 688-698
70. Liu Y., Song Z., Zhao Y., et al. A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. Biochem Biophys Res Commun 346 (2006) 131-139
71. Yao S., Chen S., Clark J., et al. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci USA 103 (2006) 6907-6912
72. Ludwig T.E., Levenstein M.E., Jones J.M., et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24 (2006) 185-187
73. Lang K.J., Rathjen J., Vassilieva S., and Rathjen P.D. Differentiation of embryonic stem cells to a neural fate: a route to re-building the nervous system?. J Neurosci Res 76 (2004) 184-192
74. Santana A., Ensenat-Waser R., Arribas M.I., Reig J.A., and Roche E. Insulin-producing cells derived from stem cells: recent progress and future directions. J Cell Mol Med 10 (2006) 866-883
75. Wobus A.M., and Boheler K.R. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85 (2005) 635-678
76. Grapin-Botton A., and Melton D.A. Endoderm development: from patterning to organogenesis. Trends Genet 16 (2000) 124-130
77. Jung J., Zheng M., Goldfarb M., and Zaret K.S. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 284 (1999) 1998-2003
78. Rossi J.M., Dunn N.R., Hogan B.L., and Zaret K.S. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 15 (2001) 1998-2009
79. Lemaigre F., and Zaret K.S. Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr Opin Genet Dev 14 (2004) 582-590
80. Shiojiri N., Inujima S., Ishikawa K., Terada K., and Mori M. Cell lineage analysis during liver development using the spf(ash)-heterozygous mouse. Lab Invest 81 (2001) 17-25
81. Duncan S.A. Mechanisms controlling early development of the liver. Mech Dev 120 (2003) 19-33
82. Zaret K.S. Molecular genetics of early liver development. Annu Rev Physiol 58 (1996) 231-251
83. Zaret K.S. Regulatory phases of early liver development: paradigms of organogenesis. Nat Rev Genet 3 (2002) 499-512
84. Nowak G., Ericzon B.G., Nava S., Jaksch M., Westgren M., and Sumitran-Holgersson S. Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo. Gut 54 (2005) 972-979
85. Suzuki A., Zheng Yw Y.W., Kaneko S., et al. Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol 156 (2002) 173-184
86. Wang J., Clark J.B., Rhee G.S., Fair J.H., Reid L.M., and Gerber D.A. Proliferation and hepatic differentiation of adult-derived progenitor cells. Cells Tissues Organs 173 (2003) 193-203
87. Hengstler J.G., Brulport M., Schormann W., et al. Generation of human hepatocytes by stem cell technology: definition of the hepatocyte. Expert Opin Drug Metab Toxicol 1 (2005) 61-74
88. Lee K.D., Kuo T.K., Whang-Peng J., et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40 (2004) 1275-1284
89. Ruhnke M., Ungefroren H., Nussler A., et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 128 (2005) 1774-1786
90. Schwartz R.E., Reyes M., Koodie L., et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109 (2002) 1291-1302
91. Hamazaki T., Iiboshi Y., Oka M., et al. Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett 497 (2001) 15-19
92. Sharma N.S., Shikhanovich R., Schloss R., and Yarmush M.L. Sodium butyrate-treated embryonic stem cells yield hepatocyte-like cells expressing a glycolytic phenotype. Biotechnol Bioeng 94 (2006) 1053-1063
93. Teratani T., Yamamoto H., Aoyagi K., et al. Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 41 (2005) 836-846
94. Jones E.A., Tosh D., Wilson D.I., Lindsay S., and Forrester L.M. Hepatic differentiation of murine embryonic stem cells. Exp Cell Res 272 (2002) 15-22
95. Yamada T., Yoshikawa M., Kanda S., et al. In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells 20 (2002) 146-154
96. Soto-Gutierrez A., Kobayashi N., Rivas-Carrillo J.D., et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol 24 (2006) 1412-1419
97. Gouon-Evans V., Boussemart L., Gadue P., et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 24 (2006) 1402-1411
98. Schuldiner M., Yanuka O., Itskovitz-Eldor J., Melton D.A., and Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 97 (2000) 11307-11312
99. Rambhatla L., Chiu C.P., Kundu P., Peng Y., and Carpenter M.K. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 12 (2003) 1-11
100. Lavon N., Yanuka O., and Benvenisty N. Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation 72 (2004) 230-238
101. Schwartz R.E., Linehan J.L., Painschab M.S., Hu W.S., Verfaillie C.M., and Kaufman D.S. Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev 14 (2005) 643-655
102. Baharvand H., Hashemi S.M., Kazemi Ashtiani S., and Farrokhi A. Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int J Dev Biol 50 (2006) 645-652
103. Soderdahl T., Kuppers-Munther B., Heins N., et al. Glutathione transferases in hepatocyte-like cells derived from human embryonic stem cells. Toxicol In Vitro 21 (2007) 929-937
104. D'Amour K.A., Agulnick A.D., Eliazer S., Kelly O.G., Kroon E., and Baetge E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23 (2005) 1534-1541
105. Cai J., Zhao Y., Liu Y., et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 45 (2007) 1229-1239
106. Foley A., and Mercola M. Heart induction: embryology to cardiomyocyte regeneration. Trends Cardiovasc Med 14 (2004) 121-125
107. Brand T. Heart development: molecular insights into cardiac specification and early morphogenesis. Dev Biol 258 (2003) 1-19
108. Hiroi Y., Kudoh S., Monzen K., et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 28 (2001) 276-280
109. Peterkin T., Gibson A., and Patient R. GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation. Embo J 22 (2003) 4260-4273
110. Plageman Jr. T.F., and Yutzey K.E. Differential expression and function of Tbx5 and Tbx20 in cardiac development. J Biol Chem 279 (2004) 19026-19034
111. Riley P., Anson-Cartwright L., and Cross J.C. The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat Genet 18 (1998) 271-275
112. Watt A.J., Battle M.A., Li J., and Duncan S.A. GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc Natl Acad Sci USA 101 (2004) 12573-12578
113. Bruneau B.G. Transcriptional regulation of vertebrate cardiac morphogenesis. Circ Res 90 (2002) 509-519
114. Olson E.N. A decade of discoveries in cardiac biology. Nat Med 10 (2004) 467-474
115. Marvin M.J., Di Rocco G., Gardiner A., Bush S.M., and Lassar A.B. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev 15 (2001) 316-327
116. Mima T., Ueno H., Fischman D.A., Williams L.T., and Mikawa T. Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc Natl Acad Sci USA 92 (1995) 467-471
117. Winnier G., Blessing M., Labosky P.A., and Hogan B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9 (1995) 2105-2116
118. Zhang H., and Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122 (1996) 2977-2986
119. Doetschman T.C., Eistetter H., Katz M., Schmidt W., and Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87 (1985) 27-45
120. Maltsev V.A., Wobus A.M., Rohwedel J., Bader M., and Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 75 (1994) 233-244
121. Metzger J.M., Lin W.I., and Samuelson L.C. Transition in cardiac contractile sensitivity to calcium during the in vitro differentiation of mouse embryonic stem cells. J Cell Biol 126 (1994) 701-711
122. Sanchez A., Jones W.K., Gulick J., Doetschman T., and Robbins J. Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. J Biol Chem 266 (1991) 22419-22426
123. Wobus A.M., Wallukat G., and Hescheler J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 48 (1991) 173-182
124. Boheler K.R., Czyz J., Tweedie D., Yang H.T., Anisimov S.V., and Wobus A.M. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 91 (2002) 189-201
125. van der Heyden M.A., van Kempen M.J., Tsuji Y., Rook M.B., Jongsma H.J., and Opthof T. P19 embryonal carcinoma cells: a suitable model system for cardiac electrophysiological differentiation at the molecular and functional level. Cardiovasc Res 58 (2003) 410-422
126. He J.Q., Ma Y., Lee Y., Thomson J.A., and Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 93 (2003) 32-39
127. Kehat I., Kenyagin-Karsenti D., Snir M., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108 (2001) 407-414
128. Reppel M., Boettinger C., and Hescheler J. Beta-adrenergic and muscarinic modulation of human embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem 14 (2004) 187-196
129. Stainier D.Y. Zebrafish genetics and vertebrate heart formation. Nat Rev Genet 2 (2001) 39-48
130. Arai A., Yamamoto K., and Toyama J. Murine cardiac progenitor cells require visceral embryonic endoderm and primitive streak for terminal differentiation. Dev Dyn 210 (1997) 344-353
131. Garcia-Martinez V., and Schoenwolf G.C. Primitive-streak origin of the cardiovascular system in avian embryos. Dev Biol 159 (1993) 706-719
132. Sugi Y., and Lough J. Anterior endoderm is a specific effector of terminal cardiac myocyte differentiation of cells from the embryonic heart forming region. Dev Dyn 200 (1994) 155-162
133. Mummery C., Ward-van Oostwaard D., Doevendans P., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107 (2003) 2733-2740
134. Mummery C.L., van Achterberg T.A., van den Eijnden-van Raaij A.J., et al. Visceral-endoderm-like cell lines induce differentiation of murine P19 embryonal carcinoma cells. Differentiation 46 (1991) 51-60
135. Kanno S., Kim P.K., Sallam K., Lei J., Billiar T.R., and Shears II L.L. Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc Natl Acad Sci USA 101 (2004) 12277-12281
136. Parisi S., D'Andrea D., Lago C.T., Adamson E.D., Persico M.G., and Minchiotti G. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J Cell Biol 163 (2003) 303-314
137. Stary M., Pasteiner W., Summer A., Hrdina A., Eger A., and Weitzer G. Parietal endoderm secreted SPARC promotes early cardiomyogenesis in vitro. Exp Cell Res 310 (2005) 331-343
138. Stary M., Schneider M., Sheikh S.P., and Weitzer G. Parietal endoderm secreted S100A4 promotes early cardiomyogenesis in embryoid bodies. Biochem Biophys Res Commun 343 (2006) 555-563
139. Takahashi T., Lord B., Schulze P.C., et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107 (2003) 1912-1916
140. Wu X., Ding S., Ding Q., Gray N.S., and Schultz P.G. Small molecules that induce cardiomyogenesis in embryonic stem cells. J Am Chem Soc 126 (2004) 1590-1591
141. Xu C., Police S., Rao N., and Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91 (2002) 501-508
142. Yoon B.S., Yoo S.J., Lee J.E., You S., Lee H.T., and Yoon H.S. Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation 74 (2006) 149-159
143. Yuasa S., Itabashi Y., Koshimizu U., et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol 23 (2005) 607-611
144. Beqqali A., Kloots J., Ward-van Oostwaard D., Mummery C., and Passier R. Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells 24 (2006) 1956-1967
145. Passier R., Oostwaard D.W., Snapper J., et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23 (2005) 772-780
146. Kwon C., Han Z., Olson E.N., and Srivastava D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signalling. Proc Natl Acad Sci USA 102 (2005) 18986-18991
147. Zhao Y., Samal E., and Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436 (2005) 214-220
148. Grepin C., Nemer G., and Nemer M. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development 124 (1997) 2387-2395
149. Kehat I., Gepstein A., Spira A., Itskovitz-Eldor J., and Gepstein L. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ Res 91 (2002) 659-661
150. Snir M., Kehat I., Gepstein A., et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285 (2003) H2355-H2363
151. Bugaisky L.B., and Zak R. Differentiation of adult rat cardiac myocytes in cell culture. Circ Res 64 (1989) 493-500
152. Lane M.A., Sastre A., Law M., and Salpeter M.M. Cholinergic and adrenergic receptors on mouse cardiocytes in vitro. Dev Biol 57 (1977) 254-269
153. Klug M.G., Soonpaa M.H., and Field L.J. DNA synthesis and multinucleation in embryonic stem cell-derived cardiomyocytes. Am J Physiol 269 (1995) H1913-H1921
154. Olivetti G., Cigola E., Maestri R., et al. Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol 28 (1996) 1463-1477
155. Norstrom A., Akesson K., Hardarson T., Hamberger L., Bjorquist P., and Sartipy P. Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes. Exp Biol Med (Maywood) 231 (2006) 1753-1762
156. Segev H., Kenyagin-Karsenti D., Fishman B., et al. Molecular analysis of cardiomyocytes derived from human embryonic stem cells. Dev Growth Differ 47 (2005) 295-306
157. Lakatta E.G., Maltsev V.A., Bogdanov K.Y., Stern M.D., and Vinogradova T.M. Cyclic variation of intracellular calcium: a critical factor for cardiac pacemaker cell dominance. Circ Res 92 (2003) e45-e50
158. Xue T., Cho H.C., Akar F.G., et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111 (2005) 11-20
159. Satin J., Kehat I., Caspi O., et al. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol 559 (2004) 479-496
160. Dolnikov K., Shilkrut M., Zeevi-Levin N., et al. Functional properties of human embryonic stem cell-derived cardiomyocytes. Ann N Y Acad Sci 1047 (2005) 66-75
161. 2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 24 (2006) 236-245
162. Klug M.G., Soonpaa M.H., Koh G.Y., and Field L.J. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 98 (1996) 216-224
163. Kolossov E., Lu Z., Drobinskaya I., et al. Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes. Faseb J 19 (2005) 577-579
164. Meyer N., Jaconi M., Landopoulou A., Fort P., and Puceat M. A fluorescent reporter gene as a marker for ventricular specification in ES-derived cardiac cells. FEBS Lett 478 (2000) 151-158
165. Muller M., Fleischmann B.K., Selbert S., et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. Faseb J 14 (2000) 2540-2548
166. Zandstra P.W., Bauwens C., Yin T., et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 9 (2003) 767-778
167. Moore J.C., van Laake L.W., Braam S.R., et al. Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies. Reprod Toxicol 20 (2005) 377-391
168. Dowell J.D., Rubart M., Pasumarthi K.B., Soonpaa M.H., and Field L.J. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 58 (2003) 336-350
169. Reinecke H., Zhang M., Bartosek T., and Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100 (1999) 193-202
170. Soonpaa M.H., Koh G.Y., Klug M.G., and Field L.J. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264 (1994) 98-101
171. McDevitt T.C., Laflamme M.A., and Murry C.E. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J Mol Cell Cardiol 39 (2005) 865-873
172. Laflamme M.A., Gold J., Xu C., et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167 (2005) 663-671
173. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
174. Laugwitz K.L., Moretti A., Lam J., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005) 647-653
175. Messina E., De Angelis L., Frati G., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95 (2004) 911-921
176. Oh H., Bradfute S.B., Gallardo T.D., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100 (2003) 12313-12318
177. Martin C.M., Meeson A.P., Robertson S.M., et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 265 (2004) 262-275
178. Pfister O., Mouquet F., Jain M., et al. CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 97 (2005) 52-61
179. Cai C.L., Liang X., Shi Y., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5 (2003) 877-889
180. Raya A., Koth C.M., Buscher D., et al. Activation of Notch signaling pathway precedes heart regeneration in zebrafish. Proc Natl Acad Sci USA 100 Suppl 1 (2003) 11889-11895
181. Rones M.S., McLaughlin K.A., Raffin M., and Mercola M. Serrate and Notch specify cell fates in the heart field by suppressing cardiomyogenesis. Development 127 (2000) 3865-3876
182. Tseng A.S., Engel F.B., and Keating M.T. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem Biol 13 (2006) 957-963
183. Engel F.B., Schebesta M., Duong M.T., et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 19 (2005) 1175-1187
184. Drukker M., Katchman H., Katz G., et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune
185. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337 (1997) 1360-1369
186. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
187. McDonnell T.J., and Oberpriller J.O. The response of the atrium to direct mechanical wounding in the adult heart of the newt, Notophthalmus viridescens. An electron-microscopic and autoradiographic study. Cell Tissue Res 235 (1984) 583-592
188. Poss K.D., Wilson L.G., and Keating M.T. Heart regeneration in zebrafish. Science 298 (2002) 2188-2190
189. McDonnell T.J., and Oberpriller J.O. The atrial proliferative response following partial ventricular amputation in the heart of the adult newt. A light and electron microscopic autoradiographic study. Tissue Cell 15 (1983) 351-363
190. Oberpriller J.O., and Oberpriller J.C. Response of the adult newt ventricle to injury. J Exp Zool 187 (1974) 249-253
191. Quaini F., Urbanek K., Beltrami A.P., et al. Chimerism of the transplanted heart. N Engl J Med 346 (2002) 5-15
192. Kajstura J., Leri A., Finato N., Di Loreto C., Beltrami C.A., and Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 95 (1998) 8801-8805
193. Beltrami A.P., Urbanek K., Kajstura J., et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344 (2001) 1750-1757
194. Linke A., Muller P., Nurzynska D., et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 102 (2005) 8966-8971
195. Davani S., Marandin A., Mersin N., et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108 Suppl 1 (2003) II253-II258
196. Schwartz R.S., and Curfman G.D. Can the heart repair itself?. N Engl J Med 346 (2002) 2-4
197. Steendijk P., Smits P.C., Valgimigli M., van der Giessen W.J., Onderwater E.E., and Serruys P.W. Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure-volume loops. Nat Clin Pract Cardiovasc Med 3 Suppl 1 (2006) S94-S100
198. Behfar A., Zingman L.V., Hodgson D.M., et al. Stem cell differentiation requires a paracrine pathway in the heart. Faseb J 16 (2002) 1558-1566
199. Himes N., Min J.Y., Lee R., et al. In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn Reson Med 52 (2004) 1214-1219
200. Hodgson D.M., Behfar A., Zingman L.V., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287 (2004) H471-H479
201. Kofidis T., de Bruin J.L., Hoyt G., et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 128 (2004) 571-578
202. Kofidis T., de Bruin J.L., Yamane T., et al. Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 22 (2004) 1239-1245
203. Menard C., Hagege A.A., Agbulut O., et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366 (2005) 1005-1012
204. Min J.Y., Yang Y., Converso K.L., et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 92 (2002) 288-296
205. Min J.Y., Yang Y., Sullivan M.F., et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 125 (2003) 361-369
206. Naito H., Nishizaki K., Yoshikawa M., et al. Xenogeneic embryonic stem cell-derived cardiomyocyte transplantation. Transplant Proc 36 (2004) 2507-2508
207. Yang Y., Min J.Y., Rana J.S., et al. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol 93 (2002) 1140-1151
208. Kehat I., Khimovich L., Caspi O., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22 (2004) 1282-1289
209. Chien K.R., Moretti A., and Laugwitz K.L. Development. ES cells to the rescue. Science 306 (2004) 239-240
210. Fraidenraich D., Stillwell E., Romero E., et al. Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells. Science 306 (2004) 247-252
211. Chien K.R. Stem cells: lost in translation. Nature 428 (2004) 607-608
212. Kadivar M., Khatami S., Mortazavi Y., Shokrgozar M.A., Taghikhani M., and Soleimani M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun 340 (2006) 639-647
213. Wobus A.M., Kaomei G., Shan J., et al. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 29 (1997) 1525-1539
214. Choi S.C., Yoon J., Shim W.J., Ro Y.M., and Lim D.S. 5-Azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med 36 (2004) 515-523
215. Jang Y.Y., Collector M.I., Baylin S.B., Diehl A.M., and Sharkis S.J. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 6 (2004) 532-539
216. Xie H., Ye M., Feng R., and Graf T. Stepwise reprogramming of B cells into macrophages. Cell 117 (2004) 663-676
217. Chen S., Zhang Q., Wu X., Schultz P.G., and Ding S. Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 126 (2004) 410-411
218. McGann C.J., Odelberg S.J., and Keating M.T. Mammalian myotube dedifferentiation induced by newt regeneration extract. Proc Natl Acad Sci USA 98 (2001) 13699-13704
219. Odelberg S.J., Kollhoff A., and Keating M.T. Dedifferentiation of mammalian myotubes induced by msx1. Cell 103 (2000) 1099-1109
220. Rosania G.R., Chang Y.T., Perez O., et al. Myoseverin, a microtubule-binding molecule with novel cellular effects. Nat Biotechnol 18 (2000) 304-308
221. Shen C.N., Slack J.M., and Tosh D. Molecular basis of transdifferentiation of pancreas to liver. Nat Cell Biol 2 (2000) 879-887
222. Skillington J., Choy L., and Derynck R. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol 159 (2002) 135-146
223. Hopkins A.L., and Groom C.R. The druggable genome. Nat Rev Drug Discov 1 (2002) 727-730
224. Zambrowicz B.P., and Sands A.T. Knockouts model the 100 best-selling drugs-will they model the next 100?. Nat Rev Drug Discov 2 (2003) 38-51
225. Ostrer H., Wilson D.I., and Hanley N.A. Human embryo and early fetus research. Clin Genet 70 (2006) 98-107
226. Scholz G., Pohl I., Genschow E., Klemm M., and Spielmann H. Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs 165 (1999) 203-211
227. Genschow E., Spielmann H., Scholz G., et al. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 32 (2004) 209-244
228. Buesen R., Visan A., Genschow E., Slawik B., Spielmann H., and Seiler A. Trends in improving the embryonic stem cell test (EST): an overview. Altex 21 (2004) 15-22
229. Bremer S., and Hartung T. The use of embryonic stem cells for regulatory developmental toxicity testing in vitro-the current status of test development. Curr Pharm Des 10 (2004) 2733-2747
230. Prentis R.A., Lis Y., and Walker S.R. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). Br J Clin Pharmacol 25 (1988) 387-396
231. Lazarou J., Pomeranz B.H., and Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Jama 279 (1998) 1200-1205
232. Masimirembwa C.M., Thompson R., and Andersson T.B. In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery. Comb Chem High Throughput Screen 4 (2001) 245-263
233. Cross D.M., and Bayliss M.K. A commentary on the use of hepatocytes in drug metabolism studies during drug discovery and development. Drug Metab Rev 32 (2000) 219-240
234. Clarke S.E., and Jeffrey P. Utility of metabolic stability screening: comparison of in vitro and in vivo clearance. Xenobiotica 31 (2001) 591-598
235. Bertz R.J., and Granneman G.R. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin Pharmacokinet 32 (1997) 210-258
236. Ingelman-Sundberg M. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 369 (2004) 89-104
237. Pelkonen O., Maenpaa J., Taavitsainen P., Rautio A., and Raunio H. Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28 (1998) 1203-1253
238. Rendic S., and Di Carlo F.J. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29 (1997) 413-580
239. Chandra P., and Brouwer K.L. The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm Res 21 (2004) 719-735
240. Hayes J.D., Flanagan J.U., and Jowsey I.R. Glutathione transferases. Annu Rev Pharmacol Toxicol 45 (2005) 51-88
241. Haimeur A., Conseil G., Deeley R.G., and Cole S.P. The MRP-related BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 5 (2004) 21-53
242. Muller M., Meijer C., Zaman G.J., et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91 (1994) 13033-13037
243. Mannervik B., Board P.G., Hayes J.D., Listowsky I., and Pearson W.R. Nomenclature for mammalian soluble glutathione transferases. Meth Enzymol 401 (2005) 1-8
244. Rowe J.D., Nieves E., and Listowsky I. Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem J 325 Pt 2 (1997) 481-486
245. Kulkarni J.S., and Khanna A. Functional hepatocyte-like cells derived from mouse embryonic stem cells: a novel in vitro hepatotoxicity model for drug screening. Toxicol In Vitro 20 (2006) 1014-1022
246. Shah R.R. The significance of QT interval in drug development. Br J Clin Pharmacol 54 (2002) 188-202
247. Schimmel K.J., Richel D.J., van den Brink R.B., and Guchelaar H.J. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 30 (2004) 181-191
248. Meinardi M.T., Gietema J.A., van Veldhuisen D.J., van der Graaf W.T., de Vries E.G., and Sleijfer D.T. Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat Rev 26 (2000) 429-447
249. Friedman M.A., Woodcock J., Lumpkin M.M., Shuren J.E., Hass A.E., and Thompson L.J. The safety of newly approved medicines: do recent market removals mean there is a problem?. Jama 281 (1999) 1728-1734
250. Schroeder K., Neagle B., Trezise D.J., Worley J., and Ionworks. HT: a new high-throughput electrophysiology measurement platform. J Biomol Screen 8 (2003) 50-64
251. Zhou Z., Gong Q., Ye B., et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 74 (1998) 230-241
252. Weerapura M., Nattel S., Chartier D., Caballero R., and Hebert T.E. A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link?. J Physiol 540 (2002) 15-27
253. Tseng G.N. I(Kr): the hERG channel. J Mol Cell Cardiol 33 (2001) 835-849
254. Davie C., Pierre-Valentin J., Pollard C., et al. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel. J Cardiovasc Electrophysiol 15 (2004) 1302-1309
255. Muzikant A.L., and Penland R.C. Models for profiling the potential QT prolongation risk of drugs. Curr Opin Drug Discov Dev 5 (2002) 127-135
256. Meyer T., Boven K.H., Gunther E., and Fejtl M. Micro-electrode arrays in cardiac safety pharmacology: a novel tool to study QT interval prolongation. Drug Saf 27 (2004) 763-772
257. Reppel M., Pillekamp F., Brockmeier K., et al. The electrocardiogram of human embryonic stem cell-derived cardiomyocytes. J Electrocardiol 38 (2005) 166-170
258. Sicouri S., Moro S., and Elizari M.V. d-Sotalol induces marked action potential prolongation and early afterdepolarizations in M but not empirical or endocardial cells of the canine ventricle. J Cardiovasc Pharmacol Ther 2 (1997) 27-38
259. Vorperian V.R., Zhou Z., Mohammad S., Hoon T.J., Studenik C., and January C.T. Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole. J Am Coll Cardiol 28 (1996) 1556-1561